Does insurance cover Ozempic in Florida?

If you’re considering GLP-1 medications like Wegovy, Ozempic, or Mounjaro for weight loss or diabetes management, you’re probably wondering: Will my insurance cover it? The short answer is—it depends. Coverage for these medications varies widely based on your insurance type, the drug’s FDA-approved use, and your state of residence.

In this guide, we’ll break down exactly how insurance coverage works for GLP-1 drugs in 2025, which plans are most likely to cover them, what prior authorization hurdles you might face, and how to access affordable options if your insurance says no.

Understanding GLP-1 Medications: Wegovy, Ozempic, and Mounjaro

Before diving into insurance coverage, let’s clarify what each of these medications is designed to treat:

• Wegovy (semaglutide): FDA-approved specifically for chronic weight management in adults with obesity (BMI ≥30) or overweight individuals (BMI ≥27) who have at least one weight-related health condition.

• Ozempic (semaglutide): FDA-approved for Type 2 diabetes management. While it contains the same active ingredient as Wegovy, insurers typically only cover Ozempic for diabetes—not for weight loss.

• Mounjaro (tirzepatide): FDA-approved for Type 2 diabetes. Its weight-loss counterpart, Zepbound, is approved for obesity treatment, but Mounjaro itself is intended for diabetes management.

The key takeaway? Insurance companies are far more likely to cover these medications when they’re prescribed for their FDA-approved indications. Using Ozempic or Mounjaro off-label for weight loss (when you don’t have diabetes) often leads to coverage denials.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Commercial Insurance Coverage for GLP-1 Medications

Coverage for Diabetes (Ozempic, Mounjaro)

If you have Type 2 diabetes, you’re in a better position for coverage. Most commercial health plans cover Ozempic and Mounjaro as part of their diabetes formularies. However, you’ll likely face:

• Prior authorization requirements: Your doctor will need to submit documentation proving you have Type 2 diabetes and that other medications (like metformin) haven’t adequately controlled your blood sugar.
• Step therapy: Many insurers require you to try first-line diabetes treatments before approving a GLP-1 medication.
• Tier 3 or 4 placement: These are brand-name specialty drugs, so expect higher copays or coinsurance (often 20-30% of the drug’s cost).

According to Cigna’s current prior authorization criteria, GLP-1 coverage for diabetes generally requires documented evidence of inadequate glycemic control on standard therapies and confirmation of Type 2 diabetes diagnosis.

Coverage for Weight Loss (Wegovy)

Coverage for Wegovy is far more restrictive. Here’s the reality:

• Many employer plans exclude obesity drugs entirely. Employers can opt out of covering weight-loss medications due to their high cost—around $1,350 per month at list price.
• If covered, strict criteria apply. Most plans that do cover Wegovy require:
• BMI ≥30 (or ≥27 with at least one weight-related comorbidity like hypertension or sleep apnea)
• Documentation of at least 6 months of supervised diet and exercise attempts
• Regular follow-up appointments showing adherence to treatment
• Evidence of at least 5% weight loss within the first 3-6 months to continue coverage

Aetna’s clinical policy, for example, requires patients to be 18 or older, have completed a comprehensive lifestyle modification program, and meet specific BMI thresholds before approving Wegovy.

Important note: Even with all requirements met, about 25-30% of commercial plans still exclude coverage for anti-obesity medications as of 2025.

Medicare Coverage: What’s Covered and What’s Not

Here’s where it gets tricky. Medicare Part D does not cover drugs prescribed solely for weight loss. This is due to a federal law that excludes ‘weight loss or weight gain’ medications from Medicare coverage.

The Exception: Cardiovascular Risk Reduction

In March 2024, Medicare began covering Wegovy for a specific use: reducing cardiovascular risk in adults with obesity and established heart disease. This means if you have both obesity and a history of heart attack, stroke, or other cardiovascular conditions, Medicare Part D may cover Wegovy—but only for heart disease management, not general weight loss.

For diabetes, Medicare Part D covers Ozempic and Mounjaro when prescribed for Type 2 diabetes. These medications are typically placed in a higher tier with significant cost-sharing (20-33% coinsurance is common for specialty-tier drugs).

Bottom line for Medicare beneficiaries: If you need a GLP-1 for weight loss alone, Medicare won’t cover it. You’ll need to explore self-pay options or patient assistance programs.

Medicaid Coverage: A State-by-State Patchwork

Medicaid coverage for GLP-1 medications varies dramatically by state. As of 2025, only about 13 states offer any coverage for weight-loss medications under Medicaid—and several are cutting or restricting that coverage due to budget constraints.

States with Coverage (But Watch for Changes)

States with No Coverage

• Texas: Excludes all obesity medications for adults ≥21. No coverage for Wegovy under Texas Medicaid (effective March 2023).
• Florida: Does not cover weight-loss drugs—utilizes federal exclusion option under Social Security Act.
• Illinois: No Medicaid coverage for anti-obesity medications as of 2025.

For Medicaid recipients: Check your state’s current formulary. Even in states that cover GLP-1s, prior authorization is always required, and you’ll need comprehensive documentation from your healthcare provider.

At Klarity Health, our providers are experienced in navigating insurance requirements and can help determine your coverage eligibility during a virtual consultation—whether you’re on commercial insurance, Medicare, or Medicaid.

Prior Authorization: What You Need to Know

Prior authorization (PA) is the biggest hurdle to getting insurance coverage for GLP-1 medications. Here’s what the process typically involves:

Common PA Requirements

1. Medical documentation:

• Current BMI calculation and measurement
• List of weight-related comorbidities (Type 2 diabetes, hypertension, sleep apnea, etc.)
• Record of previous weight-loss attempts (6+ months of documented diet and exercise)

1. Clinical justification:

• Letter of medical necessity from your prescribing provider
• Explanation of why this medication is appropriate for you
• Evidence that you’ve tried and failed on less expensive alternatives (for some plans)

1. Ongoing monitoring:

• Many plans require 3-month or 6-month check-ins
• Continuation of coverage depends on achieving weight-loss goals (typically ≥5% body weight loss)

How Long Does PA Take?

Most insurers respond to PA requests within 5-7 business days for initial submissions. If denied, the appeals process can take an additional 2-3 weeks or longer. During this time, stay in close contact with your healthcare provider’s office and be prepared to submit additional documentation if requested.

Top Reasons for Coverage Denials (And How to Appeal)

Common Denial Reasons

1. BMI doesn’t meet threshold: Your documented BMI is below 30 (or below 27 with no qualifying comorbidity)
2. Insufficient documentation: Missing records of supervised weight-loss attempts or lifestyle modification
3. Off-label use: Requesting Ozempic or Mounjaro for weight loss when you don’t have diabetes
4. Plan exclusion: Your specific insurance plan doesn’t cover anti-obesity medications at all
5. Step therapy not met: You haven’t tried required alternatives first (older weight-loss medications or initial diabetes treatments)

How to Appeal Successfully

If your claim is denied:

• Review the denial letter carefully. It will specify exactly why coverage was denied.
• Gather additional documentation. If BMI was miscalculated or a comorbidity was missed, provide corrected records.
• Submit a letter of medical necessity. Have your provider write a detailed explanation of why this medication is essential for your health.
• Cite clinical evidence. Reference FDA approval, clinical trial data, and treatment guidelines supporting GLP-1 use for your condition.
• Be persistent. Many denials are overturned on appeal when all criteria are properly documented.

Success rates vary, but patients who truly meet medical criteria see appeals succeed in approximately 30-40% of cases, especially when working with experienced healthcare providers who understand insurance requirements.

Self-Pay Options: What If Insurance Won’t Cover It?

If your insurance denies coverage—or doesn’t cover weight-loss medications at all—you still have affordable options in 2025.

Manufacturer Discount Programs

Novo Nordisk (Wegovy/Ozempic):

• Savings card for insured patients: Reduces copay to as low as $0 per month (or up to $225 off monthly) for those with commercial insurance
• Cash-pay program: Novo’s Wegovy Access initiative now offers self-pay pricing at $349/month (down from $499)

Eli Lilly (Mounjaro):

• Savings card: $25/month for commercially insured patients with Type 2 diabetes (covers up to ~$500)
• Zepbound vials: Lilly’s weight-loss formulation now available in single-dose vials at $299-$449/month depending on dose

GoodRx Partnership Pricing

In November 2025, GoodRx launched a groundbreaking discount program in partnership with Novo Nordisk:

• Introductory pricing: $199/month for the first two months of Wegovy or Ozempic
• Ongoing pricing: ~$349/month thereafter
• Availability: Accepted at nearly all major pharmacies nationwide

This represents a 60-70% discount off list prices and is one of the most accessible self-pay options available.

Patient Assistance Programs

Both Novo Nordisk and Eli Lilly offer patient assistance programs for uninsured or underinsured individuals who meet income criteria (typically below 400% of the federal poverty level). These programs can provide medications at no cost for up to one year.

A Word About Compounded Versions

Some telehealth companies and wellness clinics offer compounded semaglutide or tirzepatide at lower prices. Exercise caution: these formulations are not FDA-approved, may vary in quality and potency, and could pose safety risks. The FDA has issued warnings about compounded GLP-1 products.

At Klarity Health, we prescribe only FDA-approved medications and can help you explore legitimate savings programs and patient assistance options during your visit.

Insurance Coverage for Telehealth Weight-Loss Visits

Good news: Most insurance plans now cover telehealth consultations for weight management just as they would in-person visits.

What’s Covered

Since the COVID-19 pandemic, telehealth coverage has expanded significantly:

• Over 40 states have telehealth parity laws requiring private insurers to cover virtual visits at the same rate as in-person care
• Medicare covers telehealth for weight counseling and chronic disease management
• Medicaid programs in most states reimburse for telehealth visits, including nutrition counseling and obesity treatment

How Klarity Health Can Help

Klarity Health offers virtual consultations with licensed healthcare providers who specialize in weight management. Our services include:

• Insurance and cash-pay options: We accept most major insurance plans and also offer transparent self-pay pricing for those without coverage
• Provider availability: Access to board-certified clinicians with expertise in metabolic health and GLP-1 prescribing
• Comprehensive care: Initial evaluations, medication management, ongoing monitoring, and support—all from the comfort of home

During your virtual visit, our providers can assess your eligibility for GLP-1 medications, submit prior authorization requests on your behalf, and help you navigate insurance requirements or find affordable self-pay alternatives.

Comparing Coverage: Side-by-Side

Frequently Asked Questions

Does insurance cover Wegovy for weight loss?

It depends on your plan. Many employer-sponsored plans exclude coverage for weight-loss medications entirely. If your plan does cover Wegovy, you’ll need prior authorization showing BMI ≥30 (or ≥27 with comorbidity), documented diet/exercise attempts, and ongoing monitoring.

Can I use Ozempic for weight loss if I don’t have diabetes?

Ozempic is FDA-approved only for Type 2 diabetes. Using it off-label for weight loss typically results in insurance denial. Wegovy (the same ingredient) is the FDA-approved option for weight management.

Will Medicare cover my GLP-1 medication?

Medicare Part D covers Ozempic and Mounjaro for Type 2 diabetes. Wegovy is covered only for cardiovascular risk reduction in obese patients with heart disease—not for general weight loss.

What if my state Medicaid doesn’t cover weight-loss drugs?

If you’re in a state without Medicaid coverage for obesity medications (like Texas or Florida), explore manufacturer patient assistance programs, GoodRx discounts, or discuss alternative weight-loss treatments with your healthcare provider.

How much will I pay out-of-pocket for these medications?

With insurance: Copays range from $0-$25 (with manufacturer cards) to 20-30% coinsurance ($200-$400/month) depending on tier placement.

Without insurance: Self-pay prices range from $199-$349/month with discount programs to $1,000+ at full retail price.

How can I appeal an insurance denial?

Request a detailed denial explanation, gather additional medical documentation, have your provider submit a letter of medical necessity, and file a formal appeal through your insurance company’s process. Persistence and thorough documentation improve success rates.

Take the Next Step Toward Your Health Goals

Navigating insurance coverage for GLP-1 medications doesn’t have to be overwhelming. Whether you have commercial insurance, Medicare, or Medicaid—or you’re exploring self-pay options—Klarity Health is here to help.

Schedule a virtual consultation today to:

• Determine your eligibility for GLP-1 medications
• Get expert guidance on insurance coverage and prior authorization
• Explore affordable self-pay options and manufacturer assistance programs
• Start a personalized weight-loss or diabetes management plan with ongoing support

Our providers are available seven days a week, accept most major insurance plans, and offer transparent cash-pay pricing for those without coverage. Take control of your metabolic health with convenient, accessible care from Klarity Health.

📅 RESEARCH CURRENCY STATEMENT (Verified as of December 17, 2025)

This article reflects the most current coverage policies, pricing, and formulary information available as of December 2025. Insurance coverage for GLP-1 medications continues to evolve—several states are ending Medicaid coverage in January 2026, and manufacturer pricing programs have been updated throughout late 2025. Always verify your specific plan’s formulary and coverage criteria, as policies can change with new plan years.

Sources and Citations

1. Aetna Clinical Policy Bulletin – Weight Loss GLP-1 Agonists. May 2024. Available at: www.aetna.com

2. California Department of Health Care Services (DHCS). Medi-Cal Coverage Changes for GLP-1 Weight Loss Medications. December 2025. Available at: www.cmadocs.org

3. Texas Health and Human Services Commission. Provider Alert: Obesity Control Drug Exclusion. April 28, 2023. Available at: www.texaschildrenshealthplan.org

4. Pennsylvania Health Law Project (PHLP). Pennsylvania Medicaid Covers Newer Weight Loss Drugs. August 2024. Available at: www.phlp.org

5. KFF (Kaiser Family Foundation). Medicaid Coverage of and Spending on GLP-1 Drugs. November 4, 2024. Available at: www.kff.org

Verified coverage status and pricing are accurate as of December 17, 2025. Always check your own insurance formulary for the latest details, as policies can change with new plan years.

Source:

• https://www.aetna.com/products/rxnonmedicare/data/2024/WeightLoss%28BMI%2035%29GIP-GLP-1GLP-1AgonistsPAwithLimit6450-CUDR_05-2024.html#:~:text=%C2%B0Wegovy%3A%20Initial%20therapy%20DOA%3A%207,based%20on%20the%20following%20references
• https://www.singlecare.com/blog/cigna-prior-authorization-weight-loss/#:~:text=Cigna%20coverage%20criteria%20for%20GLP,drugs
• https://www.amwinsconnect.com/news/kaiser-permanenter-coverage-changes-glp-1-drugs-and-anti-obesity-medications-2025#:~:text=drugs%20and%20other%20AOMs%20will,with%20BMI%20less%20than%2040
• https://www.texaschildrenshealthplan.org/2023/04/28/provider-alert-non-formulary-requests-for-obesity-control-drugs#:~:text=for%20obesity%20control%20drugs%20for,Imcivree%2C%20Qysmia%2C%20Saxenda%20and%20Wegovy
• https://www.phlp.org/en/news/pennsylvania-medicaid-covers-newer-weight-loss-drugs#:~:text=Generally%2C%20to%20get%20these%20drugs,CDC%29%20charts
• https://www.cmadocs.org/newsroom/news/view/ArticleId/51074/GLP-1-medications-for-weight-loss-will-no-longer-be-covered-by-Medi-Cal#:~:text=What%20You%20Need%20to%20Know%3A,Cal%20managed%20care
• https://solutionshortcut.com/medicaid-drug-coverage-by-state-2025-2026-updates/#:~:text=VDP%20PDL%20%26%20criteria%3B%20last,com
• https://www.cmadocs.org/newsroom/news/view/ArticleId/51074/GLP-1-medications-for-weight-loss-will-no-longer-be-covered-by-Medi-Cal#:~:text=%2A%20Three%20GLP,covered%20after%20January%201%2C%202026
• https://www.forbes.com/sites/joshuacohen/2025/08/07/coverage-of-weight-loss-drugs-by-medicaid-plans-continues-to-lag/#:~:text=Medicaid%2C%20a%20federal,employees%20due%20to%20cost%20concerns
• https://www.fiercepharma.com/marketing/novo-unveils-newly-reduced-self-pay-prices-wegovy-ozempic-after-white-house-deal#:~:text=Novo%20revealed%20Monday%20that%20the,will%20still%20run%20for%20%24499